22nd Century Group, Inc (NASDAQ:XXII) Short Interest Update

22nd Century Group, Inc (NASDAQ:XXII) was the target of a large decrease in short interest in July. As of July 31st, there was short interest totaling 132,700 shares, adecreaseof28.1% from the July 15th total of 184,500 shares. Based on an average daily trading volume, of 882,400 shares, the days-to-cover ratio is presently 0.2 days. Approximately33.2% of the shares of the company are short sold. Approximately33.2% of the shares of the company are short sold. Based on an average daily trading volume, of 882,400 shares, the days-to-cover ratio is presently 0.2 days.

22nd Century Group Stock Performance

XXII opened at $2.24 on Wednesday. 22nd Century Group has a one year low of $2.18 and a one year high of $1,892.50. The stock’s fifty day moving average is $5.76 and its 200-day moving average is $25.97. The company has a market capitalization of $1.14 million, a PE ratio of 0.00 and a beta of 1.72.

22nd Century Group (NASDAQ:XXII) last posted its quarterly earnings data on Thursday, August 14th. The biotechnology company reported ($13.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($12.89). 22nd Century Group had a negative return on equity of 344.13% and a negative net margin of 80.22%.The firm had revenue of $4.08 million during the quarter, compared to the consensus estimate of $5.44 million.

Analysts Set New Price Targets

A number of brokerages recently issued reports on XXII. Weiss Ratings reissued a “sell (e)” rating on shares of 22nd Century Group in a report on Thursday, August 14th. Wall Street Zen cut shares of 22nd Century Group from a “hold” rating to a “sell” rating in a research note on Thursday, May 22nd.

Hedge Funds Weigh In On 22nd Century Group

An institutional investor recently raised its position in 22nd Century Group stock. Anson Funds Management LP grew its holdings in 22nd Century Group, Inc (NASDAQ:XXII) by 255.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 176,094 shares of the biotechnology company’s stock after purchasing an additional 126,536 shares during the period. Anson Funds Management LP owned about 7.47% of 22nd Century Group worth $254,000 as of its most recent SEC filing. 18.06% of the stock is currently owned by hedge funds and other institutional investors.

22nd Century Group Company Profile

22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.